| 752458 |
FRONTIERS IN ONCOLOGY |
The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature |
2021-10-07 |
10.3389/fonc.2021.651723 |
Garufi Giovanna, Carbognin Luisa, Orlandi Armando, Palazzo Antonella, Tortora Giampaolo, Bria Emilio |
| 752457 |
FRONTIERS IN ONCOLOGY |
Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach |
2021-10-07 |
10.3389/fonc.2021.704607 |
Guerrisi Antonino, Russillo Michelangelo, Loi Emiliano, Ganeshan Balaji, Ungania Sara, Desiderio Flora, Bruzzaniti Vicente, Falcone Italia, Renna Davide, Ferraresi Virginia, Caterino Mauro, Solivetti Francesco Maria, Cognetti Francesco, Morrone Aldo |
| 752456 |
FRONTIERS IN ONCOLOGY |
Commentary: High Expression of Cancer-IgG Is Associated With Poor Prognosis and Radioresistance via PI3K/AKT/DNA-PKcs Pathway Regulation in Lung Adenocarcinoma |
2021-10-07 |
10.3389/fonc.2021.741089 |
Yang Liu, Lu Pingan, Qu Song |
| 752455 |
FRONTIERS IN ONCOLOGY |
Comparison of: (2S,4R)-4-[18F]Fluoroglutamine, [11C]Methionine, and 2-Deoxy-2-[18F]Fluoro-D-Glucose and Two Small-Animal PET/CT Systems Imaging Rat Gliomas |
2021-10-07 |
10.3389/fonc.2021.730358 |
Miner Maxwell W. G., Liljenbäck Heidi, Virta Jenni, Helin Semi, Eskola Olli, Elo Petri, Teuho Jarmo, Seppälä Kerttu, Oikonen Vesa, Yang Guangli, Kindler-Röhrborn Andrea, Minn Heikki, Li Xiang-Guo, Roivainen Anne |
| 752454 |
FRONTIERS IN ONCOLOGY |
Association Between Serum Creatinine Concentrations and Overall Survival in Patients With Colorectal Cancer: A Multi-Center Cohort Study |
2021-10-07 |
10.3389/fonc.2021.710423 |
Yang Ming, Zhang Qi, Ruan Guo-Tian, Tang Meng, Zhang Xi, Song Meng-Meng, Zhang Xiao-Wei, Zhang Kang-Ping, Ge Yi-Zhong, Shi Han-Ping |
| 752453 |
FRONTIERS IN ONCOLOGY |
Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis |
2021-10-07 |
10.3389/fonc.2021.768128 |
Meng Jun, Wu XiaoQin, Sun Zhen, Xun RenDe, Liu MengSi, Hu Rui, Huang JianChao |
| 752452 |
FRONTIERS IN ONCOLOGY |
The Emerging Roles of Long Noncoding RNAs as Hallmarks of Lung Cancer |
2021-10-07 |
10.3389/fonc.2021.761582 |
Jiang Jun, Lu Yuan, Zhang Fang, Huang Jie, Ren Xin-ling, Zhang Rui |
| 752451 |
FRONTIERS IN ONCOLOGY |
Development of a Margin Determination Framework for Tumor-Tracking Radiation Therapy With Intraoperatively Implanted Fiducial Markers |
2021-10-07 |
10.3389/fonc.2021.753246 |
Kim Jihun, Han Min Cheol, Chang Jee Suk, Hong Chae-Seon, Kim Kyung Hwan, Byun Hwa Kyung, Park Ryeong Hwang, Koom Woong Sub, Park Seong Yong, Kim Jin Sung |
| 752450 |
FRONTIERS IN ONCOLOGY |
Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer |
2021-10-07 |
10.3389/fonc.2021.741309 |
Zhou Siyu, Sheng Nengquan, Ren Jiazi, He Qian, Zhang Yaya, Gong Jianfeng, Wang Zhigang |
| 752449 |
FRONTIERS IN ONCOLOGY |
Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer |
2021-10-07 |
10.3389/fonc.2021.681872 |
Kumar Vivek, Gupta Sameer, Chaurasia Amrita, Sachan Manisha |
